'We're ahead of the pack' in the cannabinoid drug space, says CEO of synthetic drugmaker Corbus
September 20, 2018 at 18:34 PM EDT
Jim Cramer sits down with Yuval Cohen, the CEO of a company that is creating treatments derived from manmade cannabinoids for rare diseases like cystic fibrosis.